Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $152,565 | $17,673,000 | -$6,545,000 | $14,951,000 |
| Dep. & Amort. | $63,151 | $9,238,000 | $8,728,000 | $9,170,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $86,586 | -$168,038 | $255,911 | $24,463 |
| Other Non-Cash | $50,389 | -$26,719,618 | $36,557,089 | -$24,082,416 |
| Operating Cash Flow | $352,690 | $3,373,000 | $38,996,000 | $63,047 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12,297 | -$2,250,000 | -$1,421,000 | -$1,204,000 |
| Net Acquisitions | $48 | $0 | $0 | $0 |
| Inv. Purchases | -$8,699 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $32,939 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,284 | $1,952,106 | $16,747,000 | $1,236,986 |
| Investing Cash Flow | $9,707 | -$297,894 | $15,326,000 | $32,986 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$51,468 | -$8,354,000 | -$8,306,000 | -$25,998 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$7 | $0 | $0 | -$0 |
| Dividends Paid | -$8,926 | -$17,396,000 | -$992,000 | -$17,770,000 |
| Other Fin. Act. | -$5,722 | $25,571,740 | -$0 | $17,644,268 |
| Financing Cash Flow | -$66,124 | -$178,260 | -$9,298,000 | -$151,731 |
| Forex Effect | -$25,757 | $47,077 | -$1,442,000 | -$88,118 |
| Net Chg. in Cash | $270,517 | -$405,733 | $43,585,000 | -$143,816 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $962,242 | $1,367,975 | $160,982,000 | $1,168,135 |
| End Cash | $1,232,759 | $962,242 | $204,567,000 | $1,024,319 |
| Free Cash Flow | $341,316 | $1,123,000 | $37,575,000 | $54,671 |